HSBC upgraded Moderna (MRNA) to Hold from Reduce with a $58 price target
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNA:
- Moderna (MRNA) and Other Vaccine Stocks Fall on News of RFK Jr. Health Nomination
- Cantor sees six changes to Nasdaq 100 Index in December rebalance
- Deutsche downgrades GSK to Hold on Trump’s RFK nomination
- VOO ETF Update, 11/15/2024
- Wolfe Research starts Moderna at Underperform, sees limited upside opportunity